Focus:
Tablets in blisters may seem like a simple, everyday item, but in reality the manufacturing process is highly sophisticated. The trend toward smaller batch sizes and higher numbers of packaging...
Obtaining intranasal CannatolRx’s patent in seizures was one of the last crucial pieces needed for the IND filing.
According to a source, the randomised Phase II study has Roche’s support and will start enrolling patients in a few weeks.
Clinical assessment of AbbVie and Roche’s Venclexta/Venclyxto were placed on hold by the FDA after a review of data from BELLINI trial.
Approximately 70% of all Indian pharmaceutical revenues will be from generics and revenue growth for this segment has been particularly rapid in recent years.
Purdue Pharma, which makes the drug OxyContin, and its owners, the Sackler family, came to an agreement to pay out $270M to the state of Oklahoma, in a settlement over...
AstraZeneca’s (AZ’s) Forxiga (dapagliflozin) has gained approval for use in type 1 diabetes (T1D) in both Europe and Japan on 20 March and 27 March, respectively. Diabetes type 1 treatment...
Chronic periodontitis (CP) has been identified as significant risk factors for AD and in mouse studies indicated Pg can translocate to the brain after oral infection in mice.
The largest indication by biosimilar clinical trial count is rheumatoid arthritis, followed by breast cancer, anaemia, psoriasis and Crohn’s disease.
Allergy Therapeutics suggested a meaningful response to the immunotherapy had occurred and was obscured by confounding factors in the trial.
